08037 CH BIOTECH SER
- 0.440
- +0.080+22.22%
About CH BIOTECH SER Company
China Biotechnology Services Holdings Co., Ltd. was established as a Sino-foreign joint venture in China in 1996 and listed on the GEM of the Hong Kong Stock Exchange in June 2004. The stock code is 8037.HK. The company is abbreviated as “China Biotechnology Services”. The company was included in the Hong Kong MSCI Microcap Index in May 2018. Our vision: Future biotechnology platform Lay out the two major directions of “Accurate Diagnosis: Accurate Big Health Testing System” and “Precise Treatment: Car-T Integrated Industrial Chain” ▎ Radiating Europe and America to China based on the Guangdong-Hong Kong-Macao Greater Bay Area Seize the historical opportunities of global precision medicine development and strive to become a future biotechnology platform Company philosophy: It covers various human states of health, sub-health, and disease. Through the combination of individualized life numbers and big data life cycle tables, we recognize and control customer health throughout the life cycle, and formulate targeted interventions so that diseases can be known, controllable, and treatable.
Company Profile
Company Executives
- Name
- Position
- Salary
- xiaolin liu
- Presidencies, Executive Director, Director of Compliance, Chairman of the Nomination Committee, Remuneration Committee Members, Authorized Representative
- --
- xun he
- Executive Director
- --
- song huang
- Executive Director
- --
- yuantao guo
- Independent Non-Executive Director, Audit Committee Members, Remuneration Committee Members, Nomination Committee Members
- --
- guoxiang yan
- Independent Non-Executive Director, Remuneration Committee Chairman, Chairman of the Audit Committee, Nomination Committee Members
- --
- hongji qian
- Independent Non-Executive Director, Audit Committee Members
- --
- haiyin xu
- Counselor
- 1.89M
- miaochun wang
- Authorized Representative, Company Secretary
- --
Analysis
Price Target
No Data
No Data